Interleukin-1, interleukin-1 receptor antagonist and macrophage populations in rheumatoid arthritis synovial membrane

被引:1
作者
Cauli, A [1 ]
Yanni, G [1 ]
Panayi, GS [1 ]
机构
[1] UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,GUYS HOSP,DEPT MED,DIV MED,RHEUMATOL UNIT,LONDON SE1 9RT,ENGLAND
来源
BRITISH JOURNAL OF RHEUMATOLOGY | 1997年 / 36卷 / 09期
关键词
rheumatoid arthritis; osteoarthritis; interleukin-1; interleukin-1 receptor antagonist; synovial membrane; immunohistochemistry; macrophages;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine whether interleukin-1 (IL-1) and interleukin-1 receptor antagonist (IL-1ra) are produced by different macrophage subsets, we applied immunoperoxidase and double-labelling immunofluorescence techniques to 10 rheumatoid arthritis (RA) and 10 osteoarthritis (OA) synovial membranes. In RA, greater numbers of early 27E10+ macrophages were found in the sublining layer while mature 25F9+ macrophages were more abundant in the lining layers. The majority of IL-1 alpha+ cells were also IL-1ra+ (79 +/- 12% sublining layer, 98 +/- 2% lining layer). In OA sublining layer, a higher percentage of cells double stained for 25F9 and IL-1ra was detected compared to those double stained for 25F9 and IL-1 alpha (P < 0.004). In OA, 25F9+ macrophages demonstrated a lower percentage of IL-1 alpha+ in the lining and sublining layers compared to RA (P < 0.02 and P < 0.004, respectively). It may be concluded that once monocytes have migrated into the RA joint, they undergo phenotypic and functional changes from an early profile (27E10+, CD14+, low percentage of IL-1+ and IL-1ra+ cells) to a mature profile (CD14+/-, 25F9+, RM3/1+, high percentage of IL-1+ and IL-1ra+ cells).
引用
收藏
页码:935 / 940
页数:6
相关论文
共 30 条
[1]   LIPOPOLYSACCHARIDE INDUCES HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST AND INTERLEUKIN-1 PRODUCTION IN THE SAME CELL [J].
ANDERSSON, J ;
BJORK, L ;
DINARELLO, CA ;
TOWBIN, H ;
ANDERSSON, U .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (10) :2617-2623
[2]   INTERACTION OF RECOMBINANT MONOCYTE-DERIVED INTERLEUKIN-1 RECEPTOR ANTAGONIST WITH RHEUMATOID SYNOVIAL-CELLS [J].
AREND, WP ;
COLL, BP .
CYTOKINE, 1991, 3 (05) :407-413
[3]   BIOLOGICAL PROPERTIES OF RECOMBINANT HUMAN MONOCYTE-DERIVED INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].
AREND, WP ;
WELGUS, HG ;
THOMPSON, RC ;
EISENBERG, SP .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (05) :1694-1697
[4]  
AREND WP, 1985, J IMMUNOL, V134, P3868
[5]   CYTOKINES AND CYTOKINE INHIBITORS OR ANTAGONISTS IN RHEUMATOID-ARTHRITIS [J].
AREND, WP ;
DAYER, JM .
ARTHRITIS AND RHEUMATISM, 1990, 33 (03) :305-315
[6]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[7]  
BEEKHUIZEN H, 1991, J IMMUNOL, V147, P3761
[8]  
BORASCHI D, 1989, J IMMUNOL, V143, P131
[9]  
DELEURAN BW, 1992, BRIT J RHEUMATOL, V31, P801
[10]   SIMILARITY BETWEEN THE INTERLEUKIN-1 RECEPTORS ON A MURINE T-LYMPHOMA CELL-LINE AND ON A MURINE FIBROBLAST CELL-LINE [J].
DOWER, SK ;
CALL, SM ;
GILLIS, S ;
URDAL, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (04) :1060-1064